These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29253572)

  • 41. Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC.
    Piao J; Chen L; Quan T; Li L; Quan C; Piao Y; Jin T; Lin Z
    Oncotarget; 2016 Sep; 7(37):60169-60180. PubMed ID: 27507059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
    Huang KF; Zhang GD; Huang YQ; Diao Y
    Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The expression of V-ATPase is associated with drug resistance and pathology of non-small-cell lung cancer.
    Lu Q; Lu S; Huang L; Wang T; Wan Y; Zhou CX; Zhang C; Zhang Z; Li X
    Diagn Pathol; 2013 Aug; 8():145. PubMed ID: 23984887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro.
    Xiao P; Sun LL; Wang J; Han RL; Ma Q; Zhong DS
    Acta Pharmacol Sin; 2015 Sep; 36(9):1107-12. PubMed ID: 26027660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
    Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sphingosine kinase-2 Inhibitor ABC294640 Enhances Doxorubicin-Induced Apoptosis of NSCLC Cells via Altering Survivin Expression.
    Hasanifard L; Samadi N; Rashtchizadeh N; Dastmalchi S; Karimi P
    Drug Res (Stuttg); 2018 Jan; 68(1):45-53. PubMed ID: 28950390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
    Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
    Jin H; Qiao F; Wang Y; Xu Y; Shang Y
    Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
    Ko JC; Syu JJ; Chen JC; Wang TJ; Chang PY; Chen CY; Jian YT; Jian YJ; Lin YW
    Basic Clin Pharmacol Toxicol; 2015 Dec; 117(6):383-91. PubMed ID: 26046675
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Secretory Clusterin Mediates Oxaliplatin Resistance via the Gadd45a/PI3K/Akt Signaling Pathway in Hepatocellular Carcinoma.
    Wang X; Zou F; Zhong J; Yue L; Wang F; Wei H; Yang G; Jin T; Dong X; Li J; Xiu P
    J Cancer; 2018; 9(8):1403-1413. PubMed ID: 29721050
    [No Abstract]   [Full Text] [Related]  

  • 51. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
    Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
    Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secretory Clusterin: A Promising Target for Chemoresistance of Hepatocellular Carcinoma.
    Zhang J; Wu M; Xu Y; Song Q; Zheng W
    Mini Rev Med Chem; 2020; 20(12):1153-1165. PubMed ID: 32228422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer.
    Paul I; Savage KI; Blayney JK; Lamers E; Gately K; Kerr K; Sheaff M; Arthur K; Richard DJ; Hamilton PW; James JA; O'Byrne KJ; Harkin DP; Quinn JE; Fennell DA
    J Pathol; 2011 Aug; 224(4):564-74. PubMed ID: 21706479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The proton pump inhibitor inhibits cell growth and induces apoptosis in human hepatoblastoma.
    Morimura T; Fujita K; Akita M; Nagashima M; Satomi A
    Pediatr Surg Int; 2008 Oct; 24(10):1087-94. PubMed ID: 18712525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Astaxanthin down-regulates Rad51 expression via inactivation of AKT kinase to enhance mitomycin C-induced cytotoxicity in human non-small cell lung cancer cells.
    Ko JC; Chen JC; Wang TJ; Zheng HY; Chen WC; Chang PY; Lin YW
    Biochem Pharmacol; 2016 Apr; 105():91-100. PubMed ID: 26921637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer with low cathepsin D levels is susceptible to vacuolar (H
    Kitazawa S; Nishizawa S; Nakagawa H; Funata M; Nishimura K; Soga T; Hara T
    Cancer Sci; 2017 Jun; 108(6):1185-1193. PubMed ID: 28317223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin.
    Abe A; Kokuba H
    Oncol Rep; 2013 Apr; 29(4):1333-42. PubMed ID: 23338618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of EGF-dependent apoptosis by vacuolar-type H(+)-ATPase inhibitors in A431 cells overexpressing the EGF receptor.
    Yoshimoto Y; Imoto M
    Exp Cell Res; 2002 Sep; 279(1):118-27. PubMed ID: 12213220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity.
    Kulesza DW; Carré T; Chouaib S; Kaminska B
    Exp Cell Res; 2013 Feb; 319(4):506-16. PubMed ID: 23149124
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells.
    Zoubeidi A; Ettinger S; Beraldi E; Hadaschik B; Zardan A; Klomp LW; Nelson CC; Rennie PS; Gleave ME
    Mol Cancer Res; 2010 Jan; 8(1):119-30. PubMed ID: 20068069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.